Biotechnology Assets SA
MAD:BST

Watchlist Manager
Biotechnology Assets SA Logo
Biotechnology Assets SA
MAD:BST
Watchlist
Price: 0.232 EUR -0.85% Market Closed
Market Cap: 16.9m EUR

Wall Street
Price Targets

BST Price Targets Summary
Biotechnology Assets SA

There are no price targets for BST.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Biotechnology Assets SA Competitors:
Price Targets
2256
Abbisko Cayman Ltd
78% Upside
PTCT
PTC Therapeutics Inc
6% Upside
MRNA
Moderna Inc
13% Upside
ARQT
Arcutis Biotherapeutics Inc
15% Upside
GBIO
Generation Bio Co
458% Upside
MRUS
Merus NV
3% Upside
2696
Shanghai Henlius Biotech Inc
62% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
30% Upside

Revenue
Forecast

Revenue Estimate
Biotechnology Assets SA

For the last 13 years the compound annual growth rate for Biotechnology Assets SA's revenue is 18%. The projected CAGR for the next 4 years is 130%.

18%
Past Growth
130%
Estimated Growth
Estimates Accuracy
-96%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biotechnology Assets SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Biotechnology Assets SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BST's stock price target?
Not Available

BST doesn't have any price targets made by Wall Street professionals.

What is Biotechnology Assets SA's Revenue forecast?
Projected CAGR
130%

For the last 13 years the compound annual growth rate for Biotechnology Assets SA's revenue is 18%. The projected CAGR for the next 4 years is 130%.

Back to Top